Zobrazeno 1 - 10
of 31
pro vyhledávání: '"Axelle Lascaux"'
Autor:
Gabriel Etienne, Carole Faberes, Fréderic Bauduer, Didier Adiko, François Lifermann, Corinne Dagada, Caroline Lenoir, Anna Schmitt, Emilie Klein, Marie‐Pierre Fort, Fontanet Bijou, Beatrice Turcq, Fanny Robbesyn, Françoise Durrieu, Laura Versmée, Samia Madene, Marius Moldovan, Sandrine Katsahian, Anais Charles‐Nelson, Axelle Lascaux, François‐Xavier Mahon, Stéphanie Dulucq
Publikováno v:
Cancer Medicine, Vol 10, Iss 11, Pp 3635-3645 (2021)
Abstract Background Tyrosine kinase inhibitors (TKI) can be safely discontinued in chronic phase chronic myeloid leukemia (CP‐CML) patients who had achieved a sustained deep molecular response. Based on the results of discontinuation trials, recomm
Externí odkaz:
https://doaj.org/article/e95e922c9ffa45b69d31d079ecb40d5f
Autor:
Gabriel Etienne, Stéphanie Dulucq, Françoise Huguet, Anna Schmitt, Axelle Lascaux, Sandrine Hayette, Marie‐Pierre Fort, Pierre Sujobert, Fontanet Bijou, Stéphane Morisset, Suzanne Tavitian, Audrey Bidet, Beatrice Turcq, Fanny Robbesyn, Claudine Chollet, Francis Belloc, Françoise Durrieu, François‐Xavier Mahon, Franck E. Nicolini
Publikováno v:
Cancer Medicine, Vol 8, Iss 11, Pp 5173-5182 (2019)
Abstract Purpose To assess the incidence of BCR‐ABL kinase domain (KD) mutation detection and its prognostic significance in chronic phase chronic myeloid leukemia (CP‐CML) patients treated with tyrosine kinase inhibitors (TKIs). Patients and Met
Externí odkaz:
https://doaj.org/article/6e01c6179d7a4668b2becca6369a87e0
Autor:
Charles Mesguich, Valérie Latrabe, Cyrille Hulin, Axelle Lascaux, Laurence Bordenave, Elif Hindié, Gerald Marit
Publikováno v:
Cancers, Vol 13, Iss 8, p 1938 (2021)
To compare the prognostic values of 18-FDG PET/CT (FDG-PET) and Whole-Body MRI with Diffusion-Weighted Imaging (WB-DW-MRI) in the evaluation of treatment response of Multiple Myeloma (MM) patients eligible for ASCT. Thirty patients with newly diagnos
Externí odkaz:
https://doaj.org/article/43385f74e75d4bf9935421fab40d187a
Autor:
Gabriel Etienne, Stéphanie Dulucq, Fréderic Bauduer, Didier Adiko, François Lifermann, Corinne Dagada, Caroline Lenoir, Anna Schmitt, Emilie Klein, Samia Madene, Marie-Pierre Fort, Fontanet Bijou, Marius Moldovan, Beatrice Turcq, Fanny Robbesyn, Françoise Durrieu, Laura Versmée, Sandrine Katsahian, Carole Faberes, Axelle Lascaux, François-Xavier Mahon
Publikováno v:
Cancers, Vol 12, Iss 9, p 2521 (2020)
Background: Tyrosine Kinase Inhibitors (TKIs) discontinuation in patients who had achieved a deep molecular response (DMR) offer now the opportunity of prolonged treatment-free remission (TFR). Patients and Methods: Aims of this study were to evaluat
Externí odkaz:
https://doaj.org/article/262ad16b203b43079c58ea0818468c2b
Autor:
Charles Mesguich, Cyrille Hulin, Axelle Lascaux, Laurence Bordenave, Gerald Marit, Elif Hindié
Publikováno v:
Cancers, Vol 12, Iss 6, p 1394 (2020)
The field of multiple myeloma (MM) imaging has evolved. The International Myeloma Working Group recently recommended performing 18F-fluorodeoxyglucose glucose (18FDG) positron emission tomography/computed tomography (PET/CT) with the aim of staging M
Externí odkaz:
https://doaj.org/article/b04fb21f54e14a699b8a09064e7f44dd
Autor:
Eric Lippert, Olivier Mansier, Marina Migeon, Barbara Denys, Asa Nilsson, Carolina Rosmond, Laurence Lodé, Valérie Ugo, Axelle Lascaux, Beatriz Bellosillo, Joaquin Martinez-Lopez, Dina Naguib, Nathalie Gachard, Nicolas Maroc, Sylvie Hermouet
Publikováno v:
Haematologica, Vol 99, Iss 7 (2014)
Externí odkaz:
https://doaj.org/article/7c34a8f5d62b4371bd9cd35d5dcbbca8
Autor:
Caroline Kannengiesser, Mayka Sanchez, Marion Sweeney, Gilles Hetet, Briedgeen Kerr, Erica Moran, Jose L. Fuster Soler, Karim Maloum, Thomas Matthes, Caroline Oudot, Axelle Lascaux, Corinne Pondarré, Julian Sevilla Navarro, Sudharma Vidyatilake, Carole Beaumont, Bernard Grandchamp, Alison May
Publikováno v:
Haematologica, Vol 96, Iss 6 (2011)
Background Congenital sideroblastic anemias are rare disorders with several genetic causes; they are characterized by erythroblast mitochondrial iron overload, differ greatly in severity and some occur within a syndrome. The most common cause of non-
Externí odkaz:
https://doaj.org/article/9c21bc4fe67449bcaf85e6bfc090a92d
Autor:
Srdan Verstovsek, Aaron T Gerds, Alessandro M Vannucchi, Haifa Kathrin Al-Ali, David Lavie, Andrew T Kuykendall, Sebastian Grosicki, Alessandra Iurlo, Yeow Tee Goh, Mihaela C Lazaroiu, Miklos Egyed, Maria Laura Fox, Donal McLornan, Andrew Perkins, Sung-Soo Yoon, Vikas Gupta, Jean-Jacques Kiladjian, Nikki Granacher, Sung-Eun Lee, Luminita Ocroteala, Francesco Passamonti, Claire N Harrison, Barbara J Klencke, Sunhee Ro, Rafe Donahue, Jun Kawashima, Ruben Mesa, Adi Shacham Abulafia, Bjorn Andreasson, Anna Angona, Rosa Ayala, Soo-Mee Bang, Bruce Bank, Fiorenza Barraco, Eloise Beggiato, Fleur Samantha Benghiat, MassimiliaNo Bonifacio, Claire Bories, Gabriela Borsaru, Mette Brabrand, Andrei Braester, Andes Broliden, Veronika Buxhofer-Ausch, Nathalie Cambier, Marianna Caramella, Benjamin Carpentier, Nicola Cascavilla, Maria Giraldo Castellano, Hung Chang, Chih-Cheng Chen, June-Won Cheong, Yunsuk Choi, Philip Choi, Maria Teresa Corsetti, Isabel Montero Cuadrado, Julia Cunningham, Gandhi Laurent Damaj, Valerio De Stefano, Robert Delage, Regina Garcĺa Delgado, Jose Miguel Torregrosa Diaz, Péter Dombi, Viviane Dubruille, Miklós Egyed, Daniel El Fassi, Anna Elinder-Camburn, Elena Maria Elli, Martin Ellis, Carmen Fava, Salman Fazal, Angela Fleischman, Lynda Foltz, Laura Fox, Nashat Gabrail, Jose Valentĺn Garcĺa-Gutiérrez, Aaron Gerds, Stephane Girault, Heinz Gisslinger, Alexandru Gluvacov, Joachim Göthert, Evgeni (Evgueniy) Hadjiev (Hadzhiev), Kaoutar Hafraoui, Aryan Hamed, Claire Harrison, Hans Hasselbalch, Hanns Hauser, Mark Heaney, Holger Hebart, Jesus Maria Hernandez Rivas, Victor Higuero Saavedra, Christopher Hillis, Hsin-An Hou, Jonathan How, Daniel Huang, Marek Hus, Arpad Illés, Alessandro Isidori, Vadim Ivanov, Peter Johansson, Chul Won Jung, Ilya Kirgner, Maya Koren-Michowitz, Steffen Koschmieder, Szabolcs Ors Kosztolanyi, Natalia Kreiniz, Andrew Kuykendall, Jonathan Lambert, Kamel Laribi, Axelle Lascaux, Noa Lavie, Mihaela Lazaroiu, Michael Leahy, Ewa Lech-Maranda, Won Sik Lee, Ollivier Legrand, Roberto Lemoli, James Liang, Sung-Nam Lim, Michael Loschi, Alessandro Lucchesi, Ioan Macarie, Jean-Pierre Marolleau, Maurizio Martelli, Jiri Mayer, James McCloskey, Christopher McDermott, Brandon McMahon, Priyanka Mehta, Gábor Mikala, Dragana Milojkovic, Philippe Mineur, Elena Mishchenko, Joon Ho Moon, Zsolt Nagy, Srinivasan Narayanan, Casey O'Connell, Stephen Oh, Mario Ojeda-Uribe, Kiat Hoe Ong, Folashade Otegbeye, Jeanne Palmer, Fabrizio Pane, Andrea Patriarca, Giuseppe Pietrantuono, Mark Plander, Uwe Platzbecker, Ritam Prasad, Witold Prejzner, Tobias Rachow, Atanas Radinoff, László Rejtő, Ciro Rinaldi, Tadeusz Robak, Maria Angeles Fernandez Rodriguez, Aaron Ronson, David Ross, Tomasz Sacha, Parvis Sadjadian, Antonio Salar, Guillermo Sanz Santillana, Christof Scheid, Aline Schmidt, Marianne Tang Severinsen, Vera Stoeva, Paweł Szwedyk, Mario Tiribelli, Karolin Trautmann-Grill, Amy Trottier, Nikolay Tzvetkov, Janusz van Droogenbroeck, Alessandro Vannucchi, Nicola Vianelli, Nikolas von Bubnoff, Dominik Wolf, Dariusz Woszczyk, Tomasz Woźny, Tomasz Wróbel, Blanca Xicoy, Su-Peng Yeh
Publikováno v:
Verstovsek, S, Gerds, A, Vannucchi, A, Vannucchi, A, Al-Ali, H K, Lavie, D, Kuykendall, A T, Grosicki, S, Iurlo, A, Goh, Y T, Lazaroiu, M C, Egyed, M, Fox, M L, McLornan, D, Harrison, C N, Perkins, A, Yoon, S S, Gupta, V, Kiladjian, J J, Granacher, N, Lee, S E, Ocroteala, L, Passamonti, F, Klencke, B J, Ro, S, Donahue, R, Kawashima, J, Mesa, R, MOMENTUM Study Investigators & Severinsen, M T 2023, ' Momelotinib versus danazol in symptomatic patients with anaemia and myelofibrosis (MOMENTUM) : results from an international, double-blind, randomised, controlled, phase 3 study ', The Lancet, vol. 401, no. 10373, pp. 269-280 . https://doi.org/10.1016/S0140-6736(22)02036-0
BACKGROUND: Janus kinase (JAK) inhibitors approved for myelofibrosis provide spleen and symptom improvements but do not meaningfully improve anaemia. Momelotinib, a first-in-class inhibitor of activin A receptor type 1 as well as JAK1 and JAK2, has s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9b0a29b32da77b75b50f0a41ca3581cd
https://vbn.aau.dk/da/publications/00e2be43-3d7e-42ce-a974-744fc61bd9e2
https://vbn.aau.dk/da/publications/00e2be43-3d7e-42ce-a974-744fc61bd9e2
Autor:
Francois-Xavier Mahon, Marie-Pierre Fort, Béatrice Turcq, Laura Versmée, François Lifermann, Fanny Robbesyn, Marius Moldovan, Gabriel Etienne, Anais Charles-Nelson, Didier Adiko, Caroline Lenoir, Axelle Lascaux, Anna Schmitt, C. Fabères, Frédéric Bauduer, Stéphanie Dulucq, Emilie Klein, Sandrine Katsahian, Françoise Durrieu, Fontanet Bijou, Corinne Dagada, Samia Madene
Publikováno v:
Cancer Medicine, Vol 10, Iss 11, Pp 3635-3645 (2021)
Cancer Medicine
Cancer Medicine, Wiley, 2021, 10 (11), pp.3635-3645. ⟨10.1002/cam4.3921⟩
Cancer Medicine, Wiley, In press, ⟨10.1002/cam4.3921⟩
Cancer Medicine, In press, ⟨10.1002/cam4.3921⟩
Cancer Medicine
Cancer Medicine, Wiley, 2021, 10 (11), pp.3635-3645. ⟨10.1002/cam4.3921⟩
Cancer Medicine, Wiley, In press, ⟨10.1002/cam4.3921⟩
Cancer Medicine, In press, ⟨10.1002/cam4.3921⟩
Background Tyrosine kinase inhibitors (TKI) can be safely discontinued in chronic phase chronic myeloid leukemia (CP‐CML) patients who had achieved a sustained deep molecular response. Based on the results of discontinuation trials, recommendations
Autor:
Charles Mesguich, Cyrille Hulin, Valérie Latrabe, Axelle Lascaux, Laurence Bordenave, Elif Hindié
Publikováno v:
Frontiers in Nuclear Medicine. 1
During the last two decades, the imaging landscape of multiple myeloma (MM) has evolved with whole-body imaging techniques such as fluorodeoxyglucose positron emission tomography–computed tomography (18F-FDG PET/CT) and MRI replacing X-ray skeletal